Header cover image

Global Biotech Breakthroughs

UPDATED Apr 14, 2024

Biotech stocks worldwide which are expected to become profitable in the next 3 years.

219 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

IMU

ImmunoGen		US$28.746.8%615.5%US$8.4bUS$26.83PS29.1xE45.9%n/a

0A8K

ImmunoGen		US$31.246.4%658.3%US$8.4bUS$29.16PS29.1xE45.9%n/a

XBRANE BTU

Xbrane Biopharma		kr11.60-8.7%n/akr14.8mkr1,431.06PB0.09xE126.0%n/a

ARDX

Ardelyx		US$7.06-3.6%43.5%US$1.6bUS$13.39PS13.2xE59.6%n/a

ARDX *

Ardelyx		US$113.80-18.7%n/aUS$1.6bUS$215.82PS13.2xE59.6%n/a

0EVI

Innate Pharma		€2.312.3%-23.0%€188.8m€6.20PS3.1xE30.0%n/a

7UX

Spago Nanomedical		kr0.0222.9%-64.0%kr65.2mn/aPS11xE56.0%n/a

BINV

BioInvent International		kr18.22-2.6%-39.9%kr1.2bkr83.00PS16.8xE60.1%n/a

IDDA

Innate Pharma		€2.182.8%-24.3%€188.8m€5.85PS3.1xE30.0%n/a

EGTX

Egetis Therapeutics		kr6.08-11.2%-21.5%kr1.8bkr13.13PS30.9xE85.4%n/a

9II

Biovica International		kr0.17-3.5%-75.5%kr193.3mkr1.13PS27.8xE83.0%n/a

MIRM *

Mirum Pharmaceuticals		US$479.150%n/aUS$1.2bUS$894.07PS6.6xE63.2%n/a

IPHA

Innate Pharma		€2.48-4.6%-25.7%€188.8m€6.66PS3.1xE30.0%n/a

MIRM

Mirum Pharmaceuticals		US$24.58-5.2%-4.5%US$1.2bUS$49.00PS6.2xE63.2%n/a

IPH

Innate Pharma		€2.34-0.2%-22.0%€188.8m€6.27PS3.1xE30.0%n/a

BIOVIC B

Biovica International		kr2.30-3.0%-72.4%kr193.3mkr15.00PS27.8xE83.0%n/a

P0F

Egetis Therapeutics		kr0.440%n/akr1.8bn/aPS30.9xE85.4%n/a

G1H

G1 Therapeutics		US$4.29-0.9%81.0%US$237.5mUS$8.01PS2.9xE55.1%n/a

4147

TaiMed Biologics		NT$90.10-3.1%-13.4%NT$22.8bNT$129.02PS46.4xE110.3%n/a

51KB

AVITA Medical		US$1.97-30.1%-30.1%US$254.9mUS$5.36PS5.1xE64.5%n/a

SGEN *

Seagen		US$3,711.480%14.0%US$35.9bUS$4,373.18PS17.5xE65.7%n/a

HNSA N

Hansa Biopharma		kr160.750%0%kr2.5bkr573.38PS16.7xE56.9%n/a

ISEE

IVERIC bio		US$39.950.9%236.3%US$5.5bUS$40.00PB11.6xE59.0%n/a

CJH

CanSino Biologics		HK$1.970%-60.8%HK$8.5bHK$2.92PS11.3xE124.2%0%
Page 2 of 10
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.